Development of a technique for specific labelling phagosome-derived membranous structures in dendritic cells
开发树突状细胞中特异性标记吞噬体衍生膜结构的技术
基本信息
- 批准号:10508764
- 负责人:
- 金额:$ 7.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAntigen-Presenting CellsBacteriaCarrier ProteinsCell surfaceCellsCellular StructuresCommunicable DiseasesCommunitiesComplexConfocal MicroscopyCross PresentationCytoplasmDendritic CellsDevelopmentDyesEngineeringFoundationsGenerationsGoalsHistocompatibility Antigens Class IImaging TechniquesImmuneImmune systemIntracellular TransportLabelLeadMalignant NeoplasmsMembraneModelingMolecularOutcomeParticulatePeptidesPhagocytosisPhagosomesPlayProcessProtocols documentationResearchResearch PersonnelRoleRouteScientific Advances and AccomplishmentsShapesSiteStainsStructureTechniquesVaccinesVacuoleVirusWorkadaptive immunitybasecancer celldesigninnovationlive cell imagingnovelnovel vaccinespathogenpeptide Ipreventsuccess
项目摘要
PROJECT SUMMARY/ABSTRACT
Dendritic cells (DCs) are immune cells that play a critical role in establishing adaptive immunity
through a process termed cross-presentation. A major route of cross-presentation starts with the
phagocytosis of a particulate pathogen by a DC into an intracellular vacuole called phagosome. The
phagosome is a site for assembling major histocompatibility complex class 1 (MHC-I) and antigenic
peptides into MHC-I:peptide complexes and initiating the transport of the MHC-I:peptide complexes to
the cell surface. How the MHC-I:peptide complexes are transported from the phagosome to the cell
surface is not well understood but probably through shedding membranous structures by the phagosome.
However, existing live-cell imaging techniques cannot provide a comprehensive picture of this process.
The long-term goal of this proposed research is to develop a new technique capable of specifically
labelling all membranous structures derived from a pathogen-containing phagosome in a DC undergoing
cross-presentation. This proposed technique uses highly engineered microparticles crafted to mimic
particulate pathogens while carrying a releasable membrane dye. The most innovative feature of this
proposed technique is the use of a special material to first hold the dye in the microparticle before the
microparticle is phagocytosed and then release the dye after the phagocytosis. The central hypothesis
of this study is that by delivering a membrane dye solely into a phagosome with a microparticle and
rendering the dye releasable from the microparticle, the membranous structures derived from the
phagosome can be stained by the dye. This hypothesis has been formulated on the basis of our own
preliminary results. The objective of this application, which is the next step toward attainment of the long-
term goal, is to determine whether the microparticles can be used to specifically label phagosome-derived
membranous structures in model DCs. The specific aims are to (1) establish a protocol for fabricating the
microparticles, and (2) determine whether the microparticles can be phagocytosed by model DCs and
whether the microparticle-laden phagosome can disseminate membranous structures stained by the dye.
Success of this project will prove the feasibility of this technique and lay a foundation for its further
development. The fully developed version of this technique promises to significantly advance our
understanding of cross-presentation.
项目概要/摘要
树突状细胞 (DC) 是在建立适应性免疫中发挥关键作用的免疫细胞
通过一个称为交叉演示的过程。交叉展示的主要途径始于
DC 将颗粒病原体吞噬到称为吞噬体的细胞内液泡中。这
吞噬体是组装主要组织相容性复合体 1 类 (MHC-I) 和抗原的位点
肽进入 MHC-I: 肽复合物并启动 MHC-I: 肽复合物转运至
细胞表面。 MHC-I:肽复合物如何从吞噬体转运至细胞
表面尚不清楚,但可能是通过吞噬体脱落膜结构。
然而,现有的活细胞成像技术无法提供该过程的全面图像。
这项研究的长期目标是开发一种能够专门用于
标记来自 DC 中含有病原体的吞噬体的所有膜结构
交叉演示。这项提出的技术使用高度工程化的微粒来模仿
颗粒病原体,同时携带可释放的膜染料。本作最具创新性的特点
所提出的技术是使用一种特殊材料首先将染料固定在微粒中,然后再进行染色。
微粒被吞噬,吞噬后释放染料。中心假设
这项研究的重点是,通过将膜染料仅传递到带有微粒的吞噬体中,
使染料可从微粒中释放,源自微粒的膜结构
吞噬体可以被染料染色。这个假设是在我们自己的基础上提出的
初步结果。该应用程序的目标是实现长期目标的下一步
术语目标是确定微粒是否可用于特异性标记吞噬体衍生的
模型 DC 中的膜结构。具体目标是(1)建立一个用于制造
微粒,(2) 确定微粒是否可以被模型 DC 吞噬,
载有微粒的吞噬体是否可以传播被染料染色的膜结构。
该项目的成功将证明该技术的可行性,为其进一步推广奠定基础。
发展。该技术的完全开发版本有望显着推进我们的
对交叉演示的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jingjiao Guan其他文献
Jingjiao Guan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jingjiao Guan', 18)}}的其他基金
Development of a technique for specific labelling phagosome-derived membranous structures in dendritic cells
开发树突状细胞中特异性标记吞噬体衍生膜结构的技术
- 批准号:
10665759 - 财政年份:2022
- 资助金额:
$ 7.11万 - 项目类别:
Development of a Microdevice for Photoelectrical Stimulation of Cells
细胞光电刺激微型装置的开发
- 批准号:
10263886 - 财政年份:2020
- 资助金额:
$ 7.11万 - 项目类别:
相似国自然基金
具有温度/pH双重响应和甘露糖受体靶向功能的微凝胶疫苗
- 批准号:51903233
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
基于DNA自组装技术的人工抗原呈递细胞设计构建及其免疫功能评价
- 批准号:21907073
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
高同型半胱氨酸血症放大高脂引起动脉粥样硬化早期发病--管周脂肪的抗原呈递作用
- 批准号:91439206
- 批准年份:2014
- 资助金额:270.0 万元
- 项目类别:重大研究计划
内淋巴囊上皮细胞在内耳免疫调控作用中的分子机制研究
- 批准号:81371084
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
基于短寿蛋白肿瘤疫苗诱导的抗瘤作用及其机制的研究
- 批准号:30771999
- 批准年份:2007
- 资助金额:33.0 万元
- 项目类别:面上项目
相似海外基金
Development of a technique for specific labelling phagosome-derived membranous structures in dendritic cells
开发树突状细胞中特异性标记吞噬体衍生膜结构的技术
- 批准号:
10665759 - 财政年份:2022
- 资助金额:
$ 7.11万 - 项目类别:
Integration of mononuclear phagocytes into the human gastrointestinal GOFlowChip for investigation of luminal antigen sampling
将单核吞噬细胞整合到人胃肠道 GOFlowChip 中用于腔内抗原采样研究
- 批准号:
10318511 - 财政年份:2020
- 资助金额:
$ 7.11万 - 项目类别:
Integration of mononuclear phagocytes into the human gastrointestinal GOFlowChip for investigation of luminal antigen sampling
将单核吞噬细胞整合到人胃肠道 GOFlowChip 中用于腔内抗原采样研究
- 批准号:
10019549 - 财政年份:2019
- 资助金额:
$ 7.11万 - 项目类别:
Integration of mononuclear phagocytes into the human gastrointestinal GOFlowChip for investigation of luminal antigen sampling
将单核吞噬细胞整合到人胃肠道 GOFlowChip 中用于腔内抗原采样研究
- 批准号:
10263208 - 财政年份:2019
- 资助金额:
$ 7.11万 - 项目类别:
Defining immunological mechanisms of serovar cross-reactivity to develop broad spectrum protective vaccines for typhoidal and non-typhoidal Salmonella infections in humans
定义血清型交叉反应的免疫学机制,以开发针对人类伤寒和非伤寒沙门氏菌感染的广谱保护性疫苗
- 批准号:
10584484 - 财政年份:2019
- 资助金额:
$ 7.11万 - 项目类别: